Abbott India has done with all the necessary formalities to stop selling its Xience Alpine drug-eluting stent in India. Hence, the company will not be selling the device in the country from April 26, 2018.
Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.